Even though the slide on Expected Milestones state that topline results for Rett Phase II are due in 2H-2014, the slide titled Investment Summary states that Neuren will report results from mid 2014. Its reasonably safe to assume that Rett Phase II will be the first to report.
There is no discrepancy of course but rather a narrowing of the time frame for reporting:
* H2 2014 - anywhere from 1 July - 31 December 2014
* mid 2014 - from May through to July 2014 but with the rider that it will be the second half of the year then July most likely (August if its a little late).
Results likely due within 4-5 months for the first neurodevelopmental condition. The gateway may soon open towards a treatment for autism and other neurodevelopmental disorders.
neu investor presentation, page-20
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |